Newsfeeds - Spark Newswire

1 minute read

Amarin Corp Q2 EPS $0.02 Beats $(0.03) Estimate, Sales $154.49M Beat $153.76M Estimate

Today, 10:21 PM

Amarin Corp (NASDAQ:AMRN) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.03) by 166.67 percent. This is a 100 percent increase over earnings of $0.01 per share from the

AMRN

34 minute read

Earnings Scheduled For August 5, 2021

By Benzinga Insights

Today, 10:21 PM

Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.

AAOI

2 minute read

Movers

Understanding Amarin Corp’s Unusual Options Activity

By Benzinga Insights

Today, 10:21 PM

Amarin Corp (NASDAQ:AMRN) shares experienced unusual options activity on Wednesday. The stock price moved up to $4.45 following the option alert.

AMRN

1 minute read

Amarin Shares Spike To Session High On Volume, Now Up 3%; Hearing A Judge In ‘Skinny Label’ Suit Related To Vascepa Should Go Forward

By Benzinga Newsdesk

Today, 10:21 PM

-TradeTheNews

AMRN

6 minute read

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs

By Shanthi Rexaline

Today, 10:21 PM

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies.

ABUS

2 minute read

Analyzing Amarin Corp’s Unusual Options Activity

By Benzinga Insights

Today, 10:21 PM

Shares of Amarin Corp (NASDAQ:AMRN) saw some unusual options activity on Tuesday. Following the unusual option alert, the stock price moved up to $4.25.

AMRN

2 minute read

Understanding Amarin Corp’s Unusual Options Activity

By Benzinga Insights

Today, 10:21 PM

Shares of Amarin Corp (NASDAQ:AMRN) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $4.22.

AMRN

5 minute read

The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy’s Launches Generic Vascepa, Halozyme Strikes Licensing Deal

By Shanthi Rexaline

Today, 10:21 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21)

ABCL

4 minute read

48 Biggest Movers From Yesterday

By Lisa Levin

Today, 10:21 PM

Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share.

AEI

2 minute read

Mid-Day Market Update: Crude Oil Rises 1.5%; Tarsus Pharmaceuticals Shares Slide

By Lisa Levin

Today, 10:21 PM

Midway through trading Monday, the Dow traded up 1.48% to 33,782.47 while the NASDAQ rose 0.74% to 14,134.01. The S&P also rose, gaining 1.17% to 4,215.39.

AEI